research out of the US reports a disturbing in the prevalences of both type 1 and type 2 diabetes among children over the 2001-2009 period
To investigate the risk of pancreatitis associated with the use of incretin-based treatments in patients with type 2 diabetes mellitus.
The FDA also has announced ongoing efforts to assess the risk of pancreatic associated with incretins
Incretin treatment and risk of pancreatitis in patients with type 2 diabetes mellitus: systematic review and meta-analysis of randomised and non-randomised studies